This Exclusive Interview transcript allows you to read the full conversation between Dr. Jim McDermott and Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA. Dr. McDermott discusses the SGLT-2 research at AstraZeneca, including the CVD-REAL  large outcomes trial.

In this Exclusive Interview, Dr. Jim McDermott talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA about AstraZeneca SGLT-2 research, including the CVD-REAL  large outcomes trial.